Advertisement
Screener

INSMED INC (INSM) Market Cap

3.2 / 5 stars · 43/67 Roast Me

Add as a preferred source on Google

INSMED Inc Market Cap

Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.

  • INSMED Inc market cap for the quarter ending 2026-07-31 was $21.53B, a 6.26% decline year-over-year.
  • INSMED Inc market cap for the quarter ending 2026-06-30 was $23.28B, a 9.59% increase year-over-year.
  • INSMED Inc market cap for the quarter ending 2026-05-01 was $28.89B, a 119.39% increase year-over-year.
  • INSMED Inc market cap for the quarter ending 2026-03-31 was $35.41B, a 155.14% increase year-over-year.
  • INSMED Inc market cap for fiscal 2026 was $21.53B.
  • INSMED Inc market cap for fiscal 2025 was $37.29B, a 201.14% increase from fiscal 2024.
  • INSMED Inc market cap for fiscal 2024 was $12.38B, a 170.06% increase from fiscal 2023.
  • INSMED Inc market cap for fiscal 2023 was $4.59B, a 69.20% increase from fiscal 2022.
Available history
2010-12-31 to 2026-07-31
Data captured

Historical Market Cap

DateMarket Cap
2026-07-31$21.53B
2026-06-30$23.28B
2026-05-01$28.89B
2026-03-31$35.41B
2026-02-13$32.05B
2025-12-31$37.29B
2025-10-24$34.05B
2025-09-30$30.61B
2025-08-01$22.97B
2025-06-30$21.25B
2025-05-02$13.17B
2025-03-31$13.88B
2025-02-14$14.36B
2024-12-31$12.38B
2024-10-25$12.69B
2024-09-30$13.06B
2024-08-02$12.34B
2024-06-30$11.17B
2024-05-06$3.86B
2024-03-31$4.03B
2024-02-19$4.38B
2023-12-31$4.59B
2023-10-23$3.56B
2023-09-30$3.61B
2023-07-31$3.18B
2023-06-30$3.01B
2023-05-01$2.75B
2023-03-31$2.33B
2023-02-20$2.81B
2022-12-31$2.71B
2022-10-24$2.3B
2022-09-30$2.62B
2022-08-01$2.51B
2022-06-30$2.36B
2022-05-02$2.68B
2022-03-31$2.8B
2022-02-14$2.73B
2021-12-31$3.23B
2021-10-25$3.21B
2021-09-30$3.26B
2021-08-02$2.78B
2021-06-30$3.28B
2021-05-03$3.41B
2021-03-31$3.52B
2021-02-22$4.18B
2020-12-31$3.42B
2020-10-26$3.76B
2020-09-30$3.27B
2020-08-03$2.76B
2020-06-30$2.79B
2020-04-27$1.99B
2020-03-31$1.44B
2020-02-21$2.81B
2019-12-31$2.14B
2019-10-28$1.6B
2019-09-30$1.58B
2019-07-29$1.98B
2019-06-30$2.28B
2019-05-02$2.31B
2019-03-31$2.26B
2019-02-15$2.1B
2018-12-31$1.01B
2018-10-26$1.22B
2018-09-30$1.56B
2018-07-31$1.92B
2018-06-30$1.82B
2018-04-30$1.86B
2018-03-31$1.73B
2018-02-01$2.02B
2017-12-31$2.39B
2017-10-31$2.07B
2017-09-30$2.39B
2017-07-31$1.01B
2017-06-30$1.07B
2017-04-28$1.15B
2017-03-31$1.09B
2017-02-01$937.17M
2016-12-31$820.52M
2016-10-31$803.18M
2016-09-30$898.47M
2016-08-01$719.02M
2016-06-30$610.12M
2016-05-01$751.82M
2016-03-31$783.93M
2016-02-01$837.55M
2015-12-31$1.12B
2015-10-31$1.23B
2015-09-30$1.15B
2015-07-31$1.67B
2015-06-30$1.51B
2015-04-30$1.23B
2015-03-31$1.04B
2015-02-02$770.41M
2014-12-31$770.5M
2014-10-31$704.75M
2014-09-30$647.35M
2014-07-31$671.35M
2014-06-30$784.74M
2014-04-30$547.46M
2014-03-31$747.68M

Annual Market Cap

DateMarket Cap
2026-07-31$21.53B
2025-12-31$37.29B
2024-12-31$12.38B
2023-12-31$4.59B
2022-12-31$2.71B
2021-12-31$3.23B
2020-12-31$3.42B
2019-12-31$2.14B
2018-12-31$1.01B
2017-12-31$2.39B
2016-12-31$820.52M
2015-12-31$1.12B
2014-12-31$770.5M
2013-12-31$665.33M
2012-12-31$210.66M
2011-12-31$75.74M
2010-12-31$98.62M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Zoetis Inc. (ZTS)United States$29.045B11.38
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
Advertisement